Frontiers in Psychiatry (Feb 2021)
Evidence for Progressive Cognitive Deficits in Patients With Major Depressive Disorder
- Jin Liu,
- Jin Liu,
- Bangshan Liu,
- Bangshan Liu,
- Mi Wang,
- Mi Wang,
- Yumeng Ju,
- Yumeng Ju,
- Qiangli Dong,
- Qiangli Dong,
- Xiaowen Lu,
- Xiaowen Lu,
- Jinrong Sun,
- Jinrong Sun,
- Liang Zhang,
- Liang Zhang,
- Hua Guo,
- Futao Zhao,
- Weihui Li,
- Weihui Li,
- Li Zhang,
- Li Zhang,
- Zexuan Li,
- Zexuan Li,
- Yan Zhang,
- Yan Zhang,
- Mei Liao,
- Mei Liao,
- Lingjiang Li,
- Lingjiang Li
Affiliations
- Jin Liu
- Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China
- Jin Liu
- Hunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, China
- Bangshan Liu
- Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China
- Bangshan Liu
- Hunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, China
- Mi Wang
- Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China
- Mi Wang
- Hunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, China
- Yumeng Ju
- Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China
- Yumeng Ju
- Hunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, China
- Qiangli Dong
- Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China
- Qiangli Dong
- Hunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, China
- Xiaowen Lu
- Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China
- Xiaowen Lu
- Hunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, China
- Jinrong Sun
- Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China
- Jinrong Sun
- Hunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, China
- Liang Zhang
- Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China
- Liang Zhang
- Hunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, China
- Hua Guo
- Zhumadian Psychiatric Hospital, Zhumadian, China
- Futao Zhao
- Zhumadian Psychiatric Hospital, Zhumadian, China
- Weihui Li
- Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China
- Weihui Li
- Hunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, China
- Li Zhang
- Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China
- Li Zhang
- Hunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, China
- Zexuan Li
- Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China
- Zexuan Li
- Hunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, China
- Yan Zhang
- Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China
- Yan Zhang
- Hunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, China
- Mei Liao
- Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China
- Mei Liao
- Hunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, China
- Lingjiang Li
- Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China
- Lingjiang Li
- Hunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, China
- DOI
- https://doi.org/10.3389/fpsyt.2021.627695
- Journal volume & issue
-
Vol. 12
Abstract
Background: Cognitive deficits have shown progressive feature in major depressive disorder (MDD). However, it remains unknown which component of cognitive function is progressively impaired across episodes of MDD. Here we aim to identify the progressively impaired cognitive components in patients with MDD.Methods: A comprehensive neurocognitive test battery was used to assess the cognitive components (executive function, attention, processing speed, memory, working memory, inhibition, shifting, and verbal fluency) in 35 patients with first-episode MDD (FED), 60 patients with recurrent MDD (RD) and 111 matched healthy controls (HCs). After 6 months of treatment with antidepressant, 20 FED and 36 RD patients achieved clinical remission and completed their second-time neurocognitive tests. Statistical analyses were conducted to identify the impaired cognitive components in the FED and RD groups before and after treatment, and to assess the relationship between the cognitive components and the number of episodes and total illness duration in the MDD patient group.Results: At baseline, both the FED and RD groups showed impairments in all of the cognitive components; the FED and RD groups showed no significant difference in all of the components except for shifting. After remission, only shifting in the RD group showed no significant improvement and remained in an impaired status. Furthermore, shifting was the only component negatively correlated with the number of episodes as well as the total illness duration.Conclusions: Shifting may serve as the progressive cognitive deficit across episodes of MDD.Clinical Trials Registration: Registry name: HPA function and MRI study of trauma-related depression; Registration number: ChiCTR1800014591; URL: http://www.chictr.org.cn/edit.aspx?pid=24669&htm=4.
Keywords
- major depressive disorder
- cognitive deficit
- progression
- recurrent depression
- the number of episodes
- executive function